Woodford Patient Capital Trust

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Championing growth and supporting the best of British

Home > Funds > Woodford Patient Capital Trust plc

A uniquely attractive investment

  • Portfolio exposure to a mix of exciting, disruptive early-stage and early-growth companies, together with some of Woodford’s high conviction mid and large capitalisation ideas
  • Buying stakes in businesses with outstanding intellectual property and helping them fulfil their growth potential through the deployment of long-term patient capital
  • Aiming to identify the best, untapped growth opportunities and deliver exceptional long-term returns
  • An innovative fee structure, aligning manager and investor

The opportunity

  • Despite some of the best universities and finest intellectual property, the UK’s record of converting this into commercial success is poor
  • This is primarily due to a lack of appropriate capital investment – which creates a compelling investment opportunity
  • A long-term ‘patient capital’ approach can deliver extremely successful outcomes and help businesses fulfil their potential, while also helping to develop the UK’s ‘knowledge economy’ and support the much-needed economic rebalancing
  • Unrivalled and untapped growth opportunities offer potential for outstanding long-term returns

An investment team that shares a single goal

  • The fund is managed by Neil Woodford, widely regarded as one of the finest investors of his generation and with more than a decade’s experience of deploying long-term patient capital to young businesses
  • Neil is supported by a dedicated team that shares his approach and commitment to the goal of exceptional long-term performance for our clients
  • Three experienced fund managers work with Neil – each with a different skill set for depth of cross-market coverage
  • Three specialist analysts support the fund managers, providing them with valuable analysis and support on specific investment opportunities

Understanding early-stage risks

  • Young businesses have a very different risk profile to more mature companies – risks are much more stock-specific, which implies a lower correlation with equity markets in general and the wider economy
  • This may offer diversification benefits
  • It also means long-term outcomes are more binary – extremely attractive rewards for success but also risk of capital loss (as some businesses will inevitably fail to fulfil their potential)
  • We aim to mitigate this risk through rigorous analysis of the opportunity, an unwavering focus on valuation and diversification across a larger number of smaller positions

Who might the trust be suitable for?

  • A wide variety of UK adult investors able to invest a lump sum or make regular payments
  • Self-directed investors capable of evaluating the risks and merits of the trust (in particular the specific risks associated with investment in early-stage companies)
  • Advised investors with varied levels of interest, knowledge, confidence and experience
  • Looking for long-term (5 years+) investment growth
  • Not seeking regular income from this investment
  • Comfortable accepting that the value of investments in the trust can go down as well as up, that capital may be at risk and that performance varies over time (and share price is dependent on normal market forces of supply and demand rather than just the trust’s underlying NAV) and returns are not guaranteed

Who is this trust not suitable for?

  • Any investor who does not have sufficient resources to bear any loss resulting from the investment
  • Investors who are not prepared to take any risk with their money or put their capital at risk
  • Self-directed investors who are not able to evaluate the risks and merits of the fund
  • Any investor looking for guaranteed income or total return
  • Investors who are not prepared to accept short-term volatility as there will be periods when the fund falls in value

What are the risks?

  • The value of the fund and any income from it may go down as well as up, so you may get back less than you invested
  • Past performance cannot be relied upon as a guide to future performance
  • The annual management charge is charged to capital, so the income of the fund may be higher but capital growth may be restricted or capital may be eroded
  • The fund may invest in other transferable securities, money market instruments, warrants, collective investment schemes and deposits
  • The fund may invest in overseas securities and be exposed to currencies other than pound sterling
  • The fund may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

Before investing, you should read the Key Investor Information Document (KIID) for the fund, and the Prospectus which, along with our terms and conditions, can be obtained from the downloads page or from our registered office. If you have a financial adviser, you should seek their advice before investing. Woodford Investment Management Ltd is not authorised to provide investment advice.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2017 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement